“…Immunoreagents employed in these tests either were commercially available [13,29,36], or were produced by immunization with purified RSV [9,17], or by RSV antigens extracted by crossed immunoelectrophoresis [21]. Recently, an ELISA employing, for antigen capture, two monoclonal antibodies one specific for the NP polypeptide and the other for the fusion glycoprotein was commercialised [7,26].…”